aluates Reports

$ 0.0

Automative

Global Drug Repositioning Service Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-33Y5606

Global Drug Repositioning Service Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Drug Repositioning Service Market Research Report 2024

Code: QYRE-Auto-33Y5606

Report

June 2024

Pages:70

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Biovista Inc

Anaxomics Biotech

Segue Therapeutics

GVK Biosciences

LTT Bio-Pharma

Drug Repositioning Service Market Size

The global Drug Repositioning Service market was valued at US$ 26270 million in 2023 and is anticipated to reach US$ 36480 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.

Drug Repositioning Service Market

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drug Repositioning Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repositioning Service.

Report Scope

The Drug Repositioning Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Repositioning Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Repositioning Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug Repositioning Service Market Report

Report Metric	Details
Report Name	Drug Repositioning Service Market
Accounted market size in 2023	US$ 26270 million
Forecasted market size in 2030	US$ 36480 million
CAGR	4.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Generic Drugs Clinical Trial Failed Drugs
Segment by Application	Cardiovascular Diseases Mental Illness Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biovista, Anaxomics Biotech, Segue Therapeutics, GVK Biosciences, LTT Bio-Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Repositioning Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drug Repositioning Service Market growing?

Ans: The Drug Repositioning Service Market witnessing a CAGR of 4.7% during the forecast period 2024-2030.

What is the Drug Repositioning Service Market size in 2030?

Ans: The Drug Repositioning Service Market size in 2030 will be US$ 36480 million.

Who are the main players in the Drug Repositioning Service Market report?

Ans: The main players in the Drug Repositioning Service Market are Biovista, Anaxomics Biotech, Segue Therapeutics, GVK Biosciences, LTT Bio-Pharma

What are the Application segmentation covered in the Drug Repositioning Service Market report?

Ans: The Applications covered in the Drug Repositioning Service Market report are Cardiovascular Diseases, Mental Illness, Cancer, Other

What are the Type segmentation covered in the Drug Repositioning Service Market report?

Ans: The Types covered in the Drug Repositioning Service Market report are Generic Drugs, Clinical Trial Failed Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Repositioning Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Generic Drugs

1.2.3 Clinical Trial Failed Drugs

1.3 Market by Application

1.3.1 Global Drug Repositioning Service Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Cardiovascular Diseases

1.3.3 Mental Illness

1.3.4 Cancer

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug Repositioning Service Market Perspective (2019-2030)

2.2 Drug Repositioning Service Growth Trends by Region

2.2.1 Global Drug Repositioning Service Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Drug Repositioning Service Historic Market Size by Region (2019-2024)

2.2.3 Drug Repositioning Service Forecasted Market Size by Region (2025-2030)

2.3 Drug Repositioning Service Market Dynamics

2.3.1 Drug Repositioning Service Industry Trends

2.3.2 Drug Repositioning Service Market Drivers

2.3.3 Drug Repositioning Service Market Challenges

2.3.4 Drug Repositioning Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Repositioning Service Players by Revenue

3.1.1 Global Top Drug Repositioning Service Players by Revenue (2019-2024)

3.1.2 Global Drug Repositioning Service Revenue Market Share by Players (2019-2024)

3.2 Global Drug Repositioning Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Drug Repositioning Service Revenue

3.4 Global Drug Repositioning Service Market Concentration Ratio

3.4.1 Global Drug Repositioning Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Service Revenue in 2023

3.5 Drug Repositioning Service Key Players Head office and Area Served

3.6 Key Players Drug Repositioning Service Product Solution and Service

3.7 Date of Enter into Drug Repositioning Service Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Repositioning Service Breakdown Data by Type

4.1 Global Drug Repositioning Service Historic Market Size by Type (2019-2024)

4.2 Global Drug Repositioning Service Forecasted Market Size by Type (2025-2030)

5 Drug Repositioning Service Breakdown Data by Application

5.1 Global Drug Repositioning Service Historic Market Size by Application (2019-2024)

5.2 Global Drug Repositioning Service Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Drug Repositioning Service Market Size (2019-2030)

6.2 North America Drug Repositioning Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Drug Repositioning Service Market Size by Country (2019-2024)

6.4 North America Drug Repositioning Service Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug Repositioning Service Market Size (2019-2030)

7.2 Europe Drug Repositioning Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Drug Repositioning Service Market Size by Country (2019-2024)

7.4 Europe Drug Repositioning Service Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug Repositioning Service Market Size (2019-2030)

8.2 Asia-Pacific Drug Repositioning Service Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Drug Repositioning Service Market Size by Region (2019-2024)

8.4 Asia-Pacific Drug Repositioning Service Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drug Repositioning Service Market Size (2019-2030)

9.2 Latin America Drug Repositioning Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Drug Repositioning Service Market Size by Country (2019-2024)

9.4 Latin America Drug Repositioning Service Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Repositioning Service Market Size (2019-2030)

10.2 Middle East & Africa Drug Repositioning Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Drug Repositioning Service Market Size by Country (2019-2024)

10.4 Middle East & Africa Drug Repositioning Service Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biovista

11.1.1 Biovista Company Detail

11.1.2 Biovista Business Overview

11.1.3 Biovista Drug Repositioning Service Introduction

11.1.4 Biovista Revenue in Drug Repositioning Service Business (2019-2024)

11.1.5 Biovista Recent Development

11.2 Anaxomics Biotech

11.2.1 Anaxomics Biotech Company Detail

11.2.2 Anaxomics Biotech Business Overview

11.2.3 Anaxomics Biotech Drug Repositioning Service Introduction

11.2.4 Anaxomics Biotech Revenue in Drug Repositioning Service Business (2019-2024)

11.2.5 Anaxomics Biotech Recent Development

11.3 Segue Therapeutics

11.3.1 Segue Therapeutics Company Detail

11.3.2 Segue Therapeutics Business Overview

11.3.3 Segue Therapeutics Drug Repositioning Service Introduction

11.3.4 Segue Therapeutics Revenue in Drug Repositioning Service Business (2019-2024)

11.3.5 Segue Therapeutics Recent Development

11.4 GVK Biosciences

11.4.1 GVK Biosciences Company Detail

11.4.2 GVK Biosciences Business Overview

11.4.3 GVK Biosciences Drug Repositioning Service Introduction

11.4.4 GVK Biosciences Revenue in Drug Repositioning Service Business (2019-2024)

11.4.5 GVK Biosciences Recent Development

11.5 LTT Bio-Pharma

11.5.1 LTT Bio-Pharma Company Detail

11.5.2 LTT Bio-Pharma Business Overview

11.5.3 LTT Bio-Pharma Drug Repositioning Service Introduction

11.5.4 LTT Bio-Pharma Revenue in Drug Repositioning Service Business (2019-2024)

11.5.5 LTT Bio-Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Biovista Inc

Anaxomics Biotech

Segue Therapeutics

GVK Biosciences

LTT Bio-Pharma

List of Tables

Table 1. Global Drug Repositioning Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Generic Drugs

Table 3. Key Players of Clinical Trial Failed Drugs

Table 4. Global Drug Repositioning Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Drug Repositioning Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Drug Repositioning Service Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Drug Repositioning Service Market Share by Region (2019-2024)

Table 8. Global Drug Repositioning Service Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Drug Repositioning Service Market Share by Region (2025-2030)

Table 10. Drug Repositioning Service Market Trends

Table 11. Drug Repositioning Service Market Drivers

Table 12. Drug Repositioning Service Market Challenges

Table 13. Drug Repositioning Service Market Restraints

Table 14. Global Drug Repositioning Service Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Drug Repositioning Service Market Share by Players (2019-2024)

Table 16. Global Top Drug Repositioning Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning Service as of 2023)

Table 17. Ranking of Global Top Drug Repositioning Service Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Drug Repositioning Service Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Drug Repositioning Service Product Solution and Service

Table 21. Date of Enter into Drug Repositioning Service Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Drug Repositioning Service Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Drug Repositioning Service Revenue Market Share by Type (2019-2024)

Table 25. Global Drug Repositioning Service Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Drug Repositioning Service Revenue Market Share by Type (2025-2030)

Table 27. Global Drug Repositioning Service Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Drug Repositioning Service Revenue Market Share by Application (2019-2024)

Table 29. Global Drug Repositioning Service Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Drug Repositioning Service Revenue Market Share by Application (2025-2030)

Table 31. North America Drug Repositioning Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Drug Repositioning Service Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Drug Repositioning Service Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Drug Repositioning Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Drug Repositioning Service Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Drug Repositioning Service Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Drug Repositioning Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Drug Repositioning Service Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Drug Repositioning Service Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Drug Repositioning Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Drug Repositioning Service Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Drug Repositioning Service Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Drug Repositioning Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Drug Repositioning Service Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Drug Repositioning Service Market Size by Country (2025-2030) & (US$ Million)

Table 46. Biovista Company Detail

Table 47. Biovista Business Overview

Table 48. Biovista Drug Repositioning Service Product

Table 49. Biovista Revenue in Drug Repositioning Service Business (2019-2024) & (US$ Million)

Table 50. Biovista Recent Development

Table 51. Anaxomics Biotech Company Detail

Table 52. Anaxomics Biotech Business Overview

Table 53. Anaxomics Biotech Drug Repositioning Service Product

Table 54. Anaxomics Biotech Revenue in Drug Repositioning Service Business (2019-2024) & (US$ Million)

Table 55. Anaxomics Biotech Recent Development

Table 56. Segue Therapeutics Company Detail

Table 57. Segue Therapeutics Business Overview

Table 58. Segue Therapeutics Drug Repositioning Service Product

Table 59. Segue Therapeutics Revenue in Drug Repositioning Service Business (2019-2024) & (US$ Million)

Table 60. Segue Therapeutics Recent Development

Table 61. GVK Biosciences Company Detail

Table 62. GVK Biosciences Business Overview

Table 63. GVK Biosciences Drug Repositioning Service Product

Table 64. GVK Biosciences Revenue in Drug Repositioning Service Business (2019-2024) & (US$ Million)

Table 65. GVK Biosciences Recent Development

Table 66. LTT Bio-Pharma Company Detail

Table 67. LTT Bio-Pharma Business Overview

Table 68. LTT Bio-Pharma Drug Repositioning Service Product

Table 69. LTT Bio-Pharma Revenue in Drug Repositioning Service Business (2019-2024) & (US$ Million)

Table 70. LTT Bio-Pharma Recent Development

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Drug Repositioning Service Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Drug Repositioning Service Market Share by Type: 2023 VS 2030

Figure 3. Generic Drugs Features

Figure 4. Clinical Trial Failed Drugs Features

Figure 5. Global Drug Repositioning Service Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Drug Repositioning Service Market Share by Application: 2023 VS 2030

Figure 7. Cardiovascular Diseases Case Studies

Figure 8. Mental Illness Case Studies

Figure 9. Cancer Case Studies

Figure 10. Other Case Studies

Figure 11. Drug Repositioning Service Report Years Considered

Figure 12. Global Drug Repositioning Service Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Drug Repositioning Service Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Drug Repositioning Service Market Share by Region: 2023 VS 2030

Figure 15. Global Drug Repositioning Service Market Share by Players in 2023

Figure 16. Global Top Drug Repositioning Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning Service as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Drug Repositioning Service Revenue in 2023

Figure 18. North America Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Drug Repositioning Service Market Share by Country (2019-2030)

Figure 20. United States Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Drug Repositioning Service Market Share by Country (2019-2030)

Figure 24. Germany Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Drug Repositioning Service Market Share by Region (2019-2030)

Figure 32. China Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Drug Repositioning Service Market Share by Country (2019-2030)

Figure 40. Mexico Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Drug Repositioning Service Market Share by Country (2019-2030)

Figure 44. Turkey Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Drug Repositioning Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Biovista Revenue Growth Rate in Drug Repositioning Service Business (2019-2024)

Figure 47. Anaxomics Biotech Revenue Growth Rate in Drug Repositioning Service Business (2019-2024)

Figure 48. Segue Therapeutics Revenue Growth Rate in Drug Repositioning Service Business (2019-2024)

Figure 49. GVK Biosciences Revenue Growth Rate in Drug Repositioning Service Business (2019-2024)

Figure 50. LTT Bio-Pharma Revenue Growth Rate in Drug Repositioning Service Business (2019-2024)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions